Retinoid X receptor (RXR) agonist-induced activation of dominant- negative RXR-retinoic acid receptor α403 heterodimers is developmentally regulated during myeloid differentiation

Molecular and Cellular Biology

Volumn 19, Issue 5, 1999, Pages 3372-3382

  Johnson, Barton S ^a   Chandraratna, Roshantha A S ^b   Heyman, Richard A ^c   Allegretto, Elizabeth A ^c   Mueller, LeMoyne ^d   Collins, Steven J ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ALLERGAN INC   (United States)

^c LIGAND PHARMACEUTICALS INC   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; INTERLEUKIN 3; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

AGONIST; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSACTIVATION;

ANIMALIA;

EID: 0032947848     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.5.3372     Document Type: Article

References (63)

1. Agura, E., M. Howard, and S. J. Collins. 1992. Identification and sequence analysis of the promoter for the leukocyte integrin beta subunit (CD18): a retinoic acid-inducible gene. Blood 79:602-609.
2. Alcalay, M., D. Zangrilli, P. Pandolfi, L. Longo, A. Mencarelli, A. Giacomucci, M. Rocchi, A. Biondi, A. Rambaldi, F. LoCoco, D. Diverioi, E. Donti, F. Grignani, and P. Pelicci. 1991. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor a locus. Proc. Natl. Acad. Sci. USA 88:1977-1981.
3. Allegretto, E., M. R. McClurg, S. B. Lazarchik, D. L. Clemm, S. A. Kerner, M. G. Elgort, M. F. Boehm, S. K. White, J. W. Pike, and R. A. Heyman. 1993. Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast: correlation with hormone binding and effects of metabolism. J. Biol. Chem. 268:26625-26633.
4. Breitman, T., S. J. Collins, and B. Keene. 1981. Terminal differentiation of human promyelocytic leukemia cells in primary culture in response to retinoic acid. Blood 57:1000-1004.
5. Castaigne, S., C. Chomienne, M. Daniel, N. Berger, P. Fenaux, and L. Degos. 1990. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704-1712.
6. Cavailles, V., S. Dauvois, F. L'Horset, G. Lopez, S. Hoare, P. Kushner, and M. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:3741-3751.
7. Chen, H., R. J. Lin, R. L. Schiltz, D. Chakravarti, A. Nash, L. Nagy, M. L. Privalsky, Y. Nakatani, and R. Evans. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580.
8. Chen, J. D., and R. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
9. Collins, S. J., K. A. Robertson, and L. Mueller. 1990. Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-α). Mol. Cell. Biol. 10: 2154-2163.
10. Costa, S. L., and M. W. McBurney. 1996. Dominant negative mutant of retinoic acid receptor-α inhibits retinoic acid-induced P19 cell differentiation by binding to DNA. Exp. Cell Res. 225:35-43.
11. Damm, K., R. A. Heyman, K. Umesono, and R. M. Evans. 1993. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc. Natl. Acad. Sci. USA 90:2989-2993.
12. de The, H., A. Marchio, P. Tiollais, and A. Dejean. 1989. Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. EMBO J. 8:429-439.
13. de The, H., C. Lavfau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-684.
14. DiRenzo, J., M. Soderstrom, R. Kurokawa, M.-H. Ogliastro, M. Ricote, S. Ingrey, A. Horlein, M. Rosenfeld, and C. Glass. 1997. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol. Cell. Biol. 17:2166-2176.
15. Durand, B., M. Saunders, C. Gaudon, B. Roy, R. Losson, and P. Chambon. 1994. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13:5370-5382.
16. Forman, B., K. Umesono, J. Chen, and R. Evans. 1995. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550.
17. Giguere, V., E. Ong, P. Segui, and R. Evans. 1987. Identification of a receptor for the morphogen retinoic acid. Nature 330:624-629.
18. Grignani, F., S. De Matteis, C. Nervi, L. Tomassoni, V. Gelmetti, M. Cioce, M. Fanelli, M. Ruthardt, F. Ferrara, I. Zamir, C. Seiser, F. Grignani, M. Lazar, S. Minucci, and P. G. Pelicci. 1998. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukemia. Nature 319:815-818.
19. Halachmi, S., E. Marden, G. Martin, H. MacKay, C. Abbondanza, and M. Brown. 1994. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458.
20. He, L.-Z., F. Guidez, C. Tribioli, D. Peruzzi, M. Ruthardt, A. Zelent, and P. P. Pandolfi. 1998. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nat. Genet. 18:126-135.
21. Heinzel, T., R. Lavinsky, T. M. Mullen, M. Soderstrom, C. Laherty, J. Torchia, W.-M. Yang, G. Brard, S. Ngo, J. Davie, E. Seto, R. Eisenman, D. Rose, C. Glass, and M. Rosenfeld. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48.
22. Heyman, R. A., D. J. Mangelsdorf, J. A. Dyck, R. B. Stein, G. Eichele, R. M. Evans, and C. Thaller. 1992. 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397-406.
23. Hollenberg, S., and R. Evans. 1988. Multiple and cooperative transactivation domains of the human glucocorticoid receptor. Cell 55:899-906.
24. Hong, H., K. Kohli, M. Garabedian, and M. Stallcup. 1997. Grip1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell. Biol. 17:2735-2744.
25. Horlein, A., A. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. Glass, and M. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
26. Huang, M., Y. C. Ye, S. R. Chen, J. R. Chai, J. X. Lu, L. Zhoa, L. J. Gu, and Z. Y. Wang. 1988. Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567-574.
27. Imakado, S., J. Bickenbach, D. Bundman, J. Rothnagel, P. Attar, X.-J. Wang, V. Walczak, S. Wisniewski, J. Pote, J. Gordon, R. Heyman, R. Evans, and D. Roop. 1995. Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev. 9:317-329.
28. Johnson, A. T., E. S. Klein, S. J. Gillet, L. Wang, T. K. Song, M. E. Pino, and R. A. S. Chandraratna. 1995. Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J. Med. Chem. 38:4764-4767.
29. Kakizuka, A., W. Miller, K. Umesono, R. Warrell, S. Frankel, V. Murty, E. Dmitrovsky, and R. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663-674.
30. Kastner, P., M. Mark, and P. Chambon. 1995. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-869.
31. Kawasaki, H., R. Eckner, T.-P. Yao, K. Taira, R. Chiu, D. Livingston, and K. Yokoyama. 1998. Distinct roles of the co-activators p300 and CBP in retinoic acid-induced F9 cell differentiation. Nature 393:284-288.
32. Kurokawa, R., J. DiRenzo, M. Boehm, J. Sugarman, B. Gloss, M. Rosenfeld, R. Heyman, and C. Glass. 1994. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371:528-531.
33. Kurokawa, R., M. Soderstrom, A. Horlein, S. Halachmi, M. Brown, M. Rosenfeld, and C. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454.
34. Laherty, C., A. Billin, R. Lavinsky, G. Yochum, A. Bush, J.-M. Sun, T.-M. Mullen, J. Davie, D. Rose, C. Glass, M. Rosenfeld, D. Ayer, and R. Eisenman. 1998. SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors. Mol. Cell 2:33-42.
35. Lala, D., R. Mukherjee, I. Schulman, S. Canan Koch, L. Dardashti, A. Nadzan, G. Croston, R. Evans, and R. Heyman. 1996. Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature 383:450-453.
36. Largman, C., K. Detmer, J. Corral, F. Hack, and H. J. Lawrence. 1989. Expression of retinoic acid receptor alpha in mRNA in human leukemia cells. Blood 74:99-102.
37. Leblanc, B., and H. Stunnenberg. 1995. 9-Cis retinoic acid signaling: changing partners causes some excitement. Genes Dev. 9:1811-1816.
38. Li, H., C. Leo, D. Schroen, and J. D. Chen. 1997. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT. Mol. Endocrinol. 11:2025-2037.
39. Lin, R., L. Nagy, S. Inoue, W. Shao, W. Miller, and R. Evans. 1998. Role of the histone deacetylase complex in acute promyelocytic leukemia. Nature 391:811-814.
40. Mangelsdorf, D., K. Umesono, S. Kliewer, U. Borgmeyer, E. Ong, and R. Evans. 1991. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66:555-561.
41. Mangelsdorf, D., and R. Evans. 1995. The RXR and orphan receptors. Cell 83:841-850.
42. Morosetti, R., F. Grignani, C. Liberatore, P. Pelicci, G. Schiller, M. Kizaki, C. Bartram, C. Miller, and H. P. Koeffler. 1996. Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes and cell lines. Blood 87:4399-4403.
43. Nagy, L., H.-Y. Kao, D. Chakravarti, R. Lin, C. Hassig, D. Ayer, S. Schreiber, and R. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380.
44. Onate, S., S. Tsai, M.-J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
45. Robertson, K., B. Emami, and S. J. Collins. 1992. Retinoic acid-resistant HL-60R cells harbor a point mutation in the RA receptor ligand binding domain that confers dominant negative activity. Blood 80:1885-1889.
46. Sadowski, I., and M. Ptashne. 1989. A vector for expressing GAL4 (1-147) fusions in mammalian cells. Nucleic Acids Res. 17:753.
47. Saitou, M., S. Narumiya, and A. Kakizuka. 1994. Alteration of a single amino acid residue in retinoic acid receptor causes dominant-negative phenotype. J. Biol. Chem. 269:19101-19107.
48. Saitou, M., S. Sugai, T. Tanaka, K. Shimouchi, E. Fuchs, S. Narumiya, and A. Kakizuka. 1995. Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature 374:159-162.
49. Schulman, I., C. Li, J. W. R. Schwabe, and R. Evans. 1997. The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. Genes Dev. 11:299-308.
50. Seewaldt, V. L., L. E. Caldwell, B. S. Johnson, K. Swisshelm, S. J. Collins, and S. Tsai. 1997. Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro. Exp. Cell Res. 236:16-28.
51. Solomin, L., C. Johansson, R. Zetterstrom, R. Bissonnette, R. Heyman, L. Olson, U. Lendahl, J. Frisen, and T. Perlmann. 1998. Retinoid-X receptor signalling in the developing spinal cord. Nature 395:398-401.
52. Tate, B., G. Allenby, R. Janocha, S. Kazmer, J. Speck, L. Sturzenbecker, P. Abarzua, A. Levin, and J. Grippo. 1994. Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor α. Mol. Cell. Biol. 14:2323-2330.
53. Tsai, S., and S. Collins. 1993. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc. Natl. Acad. Sci. USA 90:7153-7157.
54. Tsai, S., S. Bartelmez, E. Sitnicka, and S. Collins. 1994. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant negative retinoic acid receptor can recapitulate lymphoid, myeloid and erythroid development. Genes Dev. 8:2831-2842.
55. Umesono, K., V. Giguere, C. Glass, M. Rosenfeld, and R. M. Evans. 1988. Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature 336:262-255.
56. 3 receptors. Cell 65:1255-1266.
57. Voegel, J., M. J. S. Heine, C. Zechel, P. Chambon, and H. Gronemeyer. 1996 TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:3667-3675.
58. Vuligonda, V., Y. Lin, and R. A. S. Chandraratna. 1996. Synthesis of highly potent RXR-specific retinoids: the use of a cyclopropyl group as a double bond isostere. Biorg. Med. Chem. Lett. 6:213-218.
59. Warrell, R., S. Frankel, W. Miller, L. Itri, M. Andreef, A. Jabukowski, J. Gabrilove, M. Gordon, and E. Dmitrovsky. 1991. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 324:1385-1390.
60. Westin, S., R. Kurokawa, R. Nolte, G. Wisely, E. McInerney, D. Rose, M. Milburn, M. Rosenfeld, and C. Glass. 1998. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 395: 199-202.
61. Willy, P., and D. J. Mangelsdorf. 1997. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev. 11:289-298.
62. Yoshida, M., M. Kijima, M. Akita, and T. Beppu. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:17174-17179.
63. Zhang, Y., Z.-W. Sun, R. Iratni, H. Erdjument-Bromage, P. Tempst, M. Hampsey, and D. Reinberg. 1998. SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex. Mol. Cell 1:1021-1031.